About This Event

Niagen Bioscience, Inc. (Nasdaq: NAGE), the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research, visits the Nasdaq MarketSite in Times Square celebrating ChromaDex Corporation evolving into Niagen Bioscience, Inc., marking a new era of uncovering the potential of NAD+ with precision science. The Company will begin trading under the new Nasdaq symbol “NAGE” at market open today, Wednesday, March 19, 2025. The CUSIP number for the Company's common stock will remain the same.

In honor of the occasion, Rob Fried, Chief Executive Officer, rings the Nasdaq Closing Bell.